1. Home
  2. EE vs COLL Comparison

EE vs COLL Comparison

Compare EE & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$35.79

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$33.71

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
COLL
Founded
2003
2002
Country
United States
United States
Employees
1046
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
EE
COLL
Price
$35.79
$33.71
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$39.20
$51.40
AVG Volume (30 Days)
362.3K
428.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
N/A
EPS
0.37
0.40
Revenue
$1,228,263,000.00
$780,567,000.00
Revenue This Year
$23.59
$8.01
Revenue Next Year
$24.37
N/A
P/E Ratio
$97.89
$87.03
Revenue Growth
44.26
23.62
52 Week Low
$21.29
$28.34
52 Week High
$43.18
$50.79

Technical Indicators

Market Signals
Indicator
EE
COLL
Relative Strength Index (RSI) 55.89 43.91
Support Level $35.10 $31.56
Resistance Level $43.18 $36.22
Average True Range (ATR) 1.44 1.70
MACD 0.26 0.00
Stochastic Oscillator 80.54 16.17

Price Performance

Historical Comparison
EE
COLL

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: